Versions :<1234Live

CDC Panel Votes to Scale Back Infant Hepatitis B Vaccine

CDC Panel Votes to Scale Back Infant Hepatitis B Vaccine
Above: Members of the CDC vaccine advisory panel at the CDC headquarters in Atlanta, Ga., on Dec. 5, 2025. Image credit: Megan Varner/Bloomberg/Getty Images

The Spin

Establishment-critical narrative

Allowing parents and doctors to decide on the Hep B birth dose protects children by matching care to actual risk. With only 0.5% of mothers testing positive and tests 100% accurate, most newborns face minimal danger. This shift promotes informed consent, real safety review and focuses resources on families who truly need protection.

Pro-establishment narrative

Ending the universal Hep B birth dose ignores decades of evidence. A safe, proven vaccine drove newborn infections from 20,000 a year to under 20. Delaying it increases the odds that children slip through the cracks and cases rise. Weakening a successful, science-based policy needlessly risks Americans' health.



Establishment split

CRITICAL

PRO



© 2025 Improve the News Foundation. All rights reserved.Version 6.18.0

© 2025 Improve the News Foundation.

All rights reserved.

Version 6.18.0